Growth Metrics

Merck (MRK) Property, Plant & Equipment (Gross) (2009 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Gross) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn -
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 54.70 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn -
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn -
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 8.42 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 13.09 Bn
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 47.23 Bn
Dec 31, 2025 47.23 Bn
Dec 31, 2024 42.93 Bn
Dec 31, 2024 42.93 Bn
Dec 31, 2023 41.32 Bn
Dec 31, 2023 41.32 Bn
Dec 31, 2022 39.41 Bn
Dec 31, 2022 39.41 Bn
Dec 31, 2021 37.47 Bn
Dec 31, 2021 37.47 Bn
Dec 31, 2020 35.16 Bn
Dec 31, 2020 35.16 Bn
Dec 31, 2019 32.74 Bn
Dec 31, 2019 32.74 Bn
Dec 31, 2018 29.62 Bn
Dec 31, 2018 29.62 Bn
Dec 31, 2017 29.04 Bn
Dec 31, 2017 29.04 Bn
Dec 31, 2016 27.78 Bn
Dec 31, 2016 27.78 Bn
Dec 31, 2015 28.43 Bn
Dec 31, 2015 28.43 Bn
Dec 31, 2014 31.14 Bn
Dec 31, 2014 31.14 Bn
Dec 31, 2013 33.09 Bn
Dec 31, 2013 33.09 Bn
Dec 31, 2012 33.42 Bn
Dec 31, 2012 33.42 Bn
Dec 31, 2011 32.47 Bn
Dec 31, 2011 32.47 Bn
Dec 31, 2010 30.56 Bn
Dec 31, 2010 30.56 Bn
Dec 31, 2009 30.87 Bn
Dec 31, 2009 30.87 Bn
Sep 30, 2009 11.01 Bn
Sep 30, 2009 11.01 Bn
Jun 30, 2009 10.79 Bn
Jun 30, 2009 10.79 Bn